Welcome to our dedicated page for Hca Healthcare news (Ticker: HCA), a resource for investors and traders seeking the latest updates and insights on Hca Healthcare stock.
HCA Healthcare operates a healthcare services network built around acute-care hospitals and ambulatory sites of care in the United States and the United Kingdom. Company news commonly addresses hospital operating trends, same-facility admissions, emergency room visits, inpatient and outpatient surgeries, revenue per equivalent admission and quarterly financial results.
Updates also cover capital allocation and financing activity, including dividends, share repurchase authorizations, commercial paper, senior notes issued by HCA Inc., and debt redemptions. Other recurring developments include hospital quality recognition, investor conference presentations, enterprise marketing and corporate affairs leadership, and the role of surgery centers, freestanding ERs, urgent care centers and physician clinics within HCA's ambulatory care platform.
HCA Healthcare (NYSE: HCA) reported 3Q 2025 results: revenues $19.161B (+9.6%), net income $1.643B (+29.4%), and EPS $6.96 (+42.6%). Adjusted EBITDA $3.870B (+18.5%). Same-facility admissions rose ~2.1% and revenue per equivalent admission +6.6%.
The company repurchased 6.514M shares for $2.498B, has $3.256B remaining buyback authorization, declared a $0.72 quarterly dividend, and ended 3Q with $997M cash and $44.511B total debt. Capital expenditures year estimate ~$5.0B.
Management raised 2025 guidance: revenues $75.0–76.5B, net income $6.495–6.715B, Adjusted EBITDA $15.25–15.65B, and EPS $27.00–28.00.
HCA Healthcare (NYSE:HCA) will host its seventh annual “Crush the Crisis” national prescription drug take back day on Oct. 25, 2025, with more than 140 collection sites partnering with local law enforcement for anonymous disposal of unused or expired medications.
HCA has helped dispose of >88,000 pounds since 2019 and aims to reach 100,000 pounds. The company cites a nearly 27% drop in national drug overdose deaths in 2024 and highlights clinical programs—Enhanced Surgical Recovery (ESR) and Electronic Prescribing of Controlled Substances (EPCS)—and its ~44 million annual patient encounters supporting prevention and safer prescribing.
HCA Healthcare (NYSE:HCA) announced its 2025 Awards of Distinction recipients, recognizing outstanding employees, physicians, and volunteers. The awards include the Frist Humanitarian Award and the Excellence in Nursing Award, representing the highest honors within the organization.
The Frist Humanitarian Award recipients include Rachel Cantarero from HCA Houston, Dr. Mohammad Subeh from Good Samaritan Hospital, and Kathy Ward from West Valley Medical Center. Each employee and volunteer recipient receives $10,000 plus $10,000 for charity, while physician recipients receive $20,000 for charity.
The Excellence in Nursing Award winners are Susan Roberts-Bradley for Professional Mentoring and Max Fransen for Compassionate Care, each receiving $10,000 plus $10,000 for charity.
HCA Healthcare (NYSE:HCA) has scheduled its third quarter 2025 earnings conference call for October 24, 2025, at 10:00 AM Eastern Time. The healthcare provider will host a live audio webcast accessible through their investor relations website.
Investors and analysts can participate in the earnings call to discuss HCA's financial performance for Q3 2025. For those unable to attend the live event, an archived version will be available on the company's website.
HCA Healthcare (NYSE:HCA) and its Foundation announced a continued collaboration with the American Heart Association through $3.9 million in funding for the Getting to the Heart of Stroke™ initiative. The program has achieved significant results since 2022, reaching over 200 million individuals with AFib and stroke risk education and expanding to more than 160 community organizations.
Key achievements include a 33% improvement in stroke cause identification at participating hospitals through enhanced care team collaboration. HCA Healthcare will expand its quality improvement efforts to all 43 comprehensive stroke centers, focusing on preventing stroke-related disability and implementing evidence-based practices.
HCA Healthcare (NYSE:HCA) has announced its participation in the upcoming Wells Fargo 2025 Healthcare Conference. The company's presentation is scheduled for September 4, 2025, at 2:15 PM ET.
Interested parties can access the live audio webcast and related presentation materials through HCA Healthcare's Investor Relations website at www.hcahealthcare.com. The company notes that presentation timing may be subject to change and recommends checking the conference schedule or company website for the most current information.
HCA Healthcare (NYSE:HCA) reported strong Q2 2025 financial results with significant growth across key metrics. Revenues increased 6.4% to $18.605 billion, while net income rose 13.1% to $1.653 billion. Diluted EPS grew 23.5% to $6.83.
The company demonstrated operational strength with same facility admissions up 1.8% and emergency room visits increasing 1.3%. Cash flows from operations more than doubled to $4.210 billion. HCA also announced a quarterly dividend of $0.72 per share and repurchased 7.031 million shares for $2.505 billion.
Following these results, HCA raised its 2025 guidance, now expecting revenues between $74.00-$76.00 billion and diluted EPS of $25.50-$27.00.
HCA Healthcare (NYSE:HCA) has appointed John W. Chidsey, III as an independent director, effective July 15, 2025. This appointment expands HCA's board from nine to ten members. Chidsey will serve on multiple committees including audit and compliance, compensation, and patient safety and quality of care.
Chidsey brings extensive corporate leadership experience as the former global CEO of Subway and Burger King Holdings, along with senior roles at Cendant Corporation and PepsiCo. He currently serves on Norwegian Cruise Line Holdings' board and previously held board positions at Encompass Health, Burger King (as chairman), and Brinker International.
["Addition of experienced corporate leader with extensive public company management expertise", "Board expansion strengthens corporate governance with new independent director", "New director brings diverse industry perspective from consumer-focused businesses"]HCA Healthcare (NYSE:HCA) has announced its upcoming second quarter 2025 earnings conference call. The call will take place on Friday, July 25, 2025, at 10:00 AM Eastern Time (9:00 AM Central).
Investors and interested parties can access the live audio webcast through the company's investor relations website. For those unable to attend the live event, an archived version of the webcast will be made available on the same platform.
HCA Healthcare (NYSE:HCA) announced that its Foundation will provide a $1 million grant to Educate Texas through its Healthier Tomorrow Fund. This grant builds upon a previous $1.35 million grant from 2022 and aims to expand healthcare career pathways in P-TECH schools.
The initial collaboration has already increased healthcare career programs from 20 to 104 schools, enrolling nearly 10,000 high school students. The P-TECH model enables students to earn both a high school diploma and a no-cost, two-year post-secondary degree. The new funding will support program expansion across North Texas, Austin, San Antonio, and the Houston Gulf Coast region.
The HCA Healthcare Foundation's Healthier Tomorrow Fund has provided over $21 million in grants nationwide, demonstrating HCA's commitment to strengthening the healthcare workforce through various educational initiatives.